Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook

INTRODUCTION: Despite maximal surgical resection and chemoradiation, glioblastoma (GBM) continues to be associated with significant morbidity and mortality. Novel therapeutic strategies are urgently needed. Given success in treating multiple other forms of cancer, checkpoint inhibitor immunotherapy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Expert Rev Clin Pharmacol
Asıl Yazarlar: Gedeon, Patrick C., Champion, Cosette D., Rhodin, Kristen E., Woroniecka, Karolina, Kemeny, Hanna R., Bramall, Alexa N., Bernstock, Joshua D., Choi, Bryan D., Sampson, John H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658017/
https://ncbi.nlm.nih.gov/pubmed/32862726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2020.1817737
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller